TAGS: Natural/ Organic
Skin Care
Demetrix Inc., a biotechnology company that makes safe, legal and effective cannabinoids, launches sampling program for the rare cannabinoid cannabigerol (CBG). The program makes CBG available in samples up to tens of grams to companies developing skincare, pharmaceutical, and other health and wellness products using cannabinoids.
New Fermentation Technology Platform
There is a massive commercial market for common cannabinoids like CBD, which is found in high concentrations in cannabis and hemp plants. However, rare cannabinoids like CBG, which show promise for a range of benefits, are typically found in quantities below one percent in the plant, making them impossible to access, study, and use.
Demetrix has created an industry-leading fermentation technology platform that allows the company to produce rare cannabinoids like CBG faster, more sustainably, at greater purity, and more affordably than traditional methods.
“
We are excited to get samples of CBG into the hands of innovative companies that are creating the next generation of products using cannabinoids,” commented chief commerical officer, Cindy Bryant.
New Platform to Produce Highly Pure CBG
Demetrix believes in the power of science to make the world a better place. The new fermentation platform allows the company to produce highly pure CBG that is always THC-free, and Demetrix’s foundational research shows CBG has promising skin health applications due to its antioxidant and anti-inflammatory performance.
“
With the intense interest in cannabinoids and the promising performance for skin health, we expect CBG to have strong consumer imagery and marketing potential. We are excited to get samples of CBG into the hands of innovative companies that are creating the next generation of products using cannabinoids,” said Cindy Bryant, Chief Commercial Officer at Demetrix.
Source: Demetrix